Conversion therapy combined with robot assisted right hemihepatectomy for a patient with hepatocellular carcinoma through Laennec approach

doi:10.3877/cma.j.issn.1674-6899.2023.02.011

Abstract

Abstract:

Objective

To summarize the feasibility and advantages of robot assisted right hemihepatectomy in a patient with advanced hepatocellular carcinoma underwent conversion therapy.

Methods

A retrospective analysis of the clinical data about a patient underwent this novel procedure in the Department of General Surgery, Gulou Hospital Affiliated to the School of Medicine of Nanjing University in Aug. 2022.

Results

The patient with advanced hepatocellular carcinoma underwent conversion therapy, whose tumor was successfully downstaged, and received radical surgery. Less intraoperative bleeding, no postoperative infection, bleeding, biliary fistula and so on. Tumor markers and related imaging examinations showed no abnormalities 6 months after the surgery.

Conclusions

It is expected to improve the long-term prognosis of patients with advanced hepatocellular carcinoma by applying the concept of conversion therapy combined with Laennec approach minimally invasive endoscopy to enhance the pathological remission rate and surgical resection rate.

Key words: Hepatocellular carcinoma, Conversion therapy, Robot assisted surgery, Hepatectomy

Yajuan Cao, Binghua Li, Decai Yu. Conversion therapy combined with robot assisted right hemihepatectomy for a patient with hepatocellular carcinoma through Laennec approach[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(02): 116-119.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6899.2023.02.011

https://zhqjwkzz.cma-cmc.com.cn/EN/Y2023/V16/I02/116

1	中国抗癌协会肝癌专业委员会转化治疗协作组. 肝癌转化治疗中国专家共识(2021版)[J]．中国实用外科杂志，2021，41(6): 618-631.
2	肖治宇，陈亚进. 不可切除中晚期肝癌的转化治疗后肝切除术[J]．中国实用外科杂志，2021, 41(3): 275-280.
3	秦建民. 原发性肝癌转化治疗指征与选择策略[J]．世界华人消化杂志，2021, 29(10): 501-510.
4	Qu WF, Ding ZB, Qu XD, et al. Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study[J]. BJS Open，2022，6(5): 114.
5	曹亚娟，张来柱，余德才. 新辅助联合机器人右半肝切除治疗进展期肝癌：Laennec入路联合背侧入路[J/CD]. 中华腔镜外科杂志(电子版), 2022, 15(2)：115-116.
6	Hu Y, Shi J, Wang S, et al. Laennec′s approach for laparoscopic anatomic hepatectomy based on Laennec′s capsule[J]. BMC Gastroenterology, 2019, 19(1)：194.

[1]	Xuebing Shi, Yingdong Xie, Ni Xie, Chaoli Xu, Bin Yang, Guo Sun. Acoustic radiation force imaging for evaluating efficacy of radiotherapy in unresectable hepatocellular carcinoma patients with portal vein tumor thrombus [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(08): 778-784.
[2]	Kai Zhong, Tiemin Jiang, Ruiqing Zhang, Yingmei Shao, Qiang Guo. Application of enhanced recovery after surgery in hepatectomy for hepatic cystic echinococcosis [J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(06): 425-429.
[3]	Junying Gao, Haizhou Zhang, Hongle Qu, Qiang Sun. Progress in the application of FOLFOX-HAIC-based adjuvant translational therapy for hepatocellular carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(06): 457-463.
[4]	Chenglin Piao, Xin Lan, Zhenduo Si, Qiang Li, Jian Feng, Fengduo An, Jianjun Leng. Analysis of the therapeutic effect of pancreaticoduodenectomy combined with liver resection: A report of 5 cases (video attached) [J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(05): 363-367.
[5]	Huazhi Li, Guang Cao, Diangang Liu, Yajing Zhang. Clinical comparison of descending hepatectomy with different approaches for primary hepatocellular carcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 52-55.
[6]	Wang Feng, Zhenzhong Ma, Linhua Tang. Clinical study of CT scanning 3D reconstruction in laparoscopic hepatectomy for intrahepatic cholangiocarcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 104-107.
[7]	Quanyou Lai, Yuan Gao, Jianlin Wang, Shibin Qu, Dan Wei, Wei Peng. Effects of 3D reconstruction technology combined with laparoscopic precision hepatectomy on the levels of CD4+, CD8+ and immunoglobulin in patients with liver cancer after surgery [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 651-654.
[8]	Mei Tang, Li Zhou, Cenyue Niu, Xiaotong Zhou, Qian Wang. Clinical significance of ICG fluorescence guided laparoscopic hepatectomy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 655-658.
[9]	Yiliang Li, Yakufu Sulayiman, Maimaitiming Maimaitiaili, Abudoureyimu Kelimu. An analysis of short-term outcomes of robotic-assisted versus conventional laparoscopic esophageal hiatal hernia repair combined with nissen fundoplication [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(05): 512-517.
[10]	Yi Hang, Xiaoyong Yang, Wenmei Li, Lei Xue. Optimal central venous pressure of controllable low central venous pressure technique in hepatectomy [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 813-817.
[11]	Zhendong Jiao, Peng Hui, Shangbo Jin. Application of three-dimensional visualization combined with ICG imaging technology in laparoscopic hepatectomy for recurrent hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 859-864.
[12]	Jing Wu, Hao Wen. New progress in liver function evaluation before hepatectomy [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 889-893.
[13]	Xueyun Wu, Xiaojun Hu, Yingfang Fan. Evaluation and prediction of residual liver regeneration ability for hepatectomy [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 894-897.
[14]	Weijie Chen, Xiaodong He. Progress in immunotargeted therapy for gallbladder cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 763-768.
[15]	Ziyang Wang, Hongbin Wang, Xiaojing Liu. Progress in research of serum markers for diagnosis of alpha-fetoprotein negative hepatocellular carcinoma [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 677-681.

Please choose a citation manager

Content to export